Literature DB >> 25349789

Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy.

Shu-Ling Wu1, Dong-Mei Zhan1, Shu-Hong Xi1, Xiang-Lian He1.   

Abstract

AIM: To investigate the role of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) in proliferative diabetic retinopathy (PDR) and to discuss the correlations among t-PA, PAI and vascular endothelial growth factor (VEGF) expressions.
METHODS: A total of 36 vitreous samples were collected from 36 patients with PDR (PDR group), and 17 vitreous samples from 17 patients with idiopathic macular hole were used as control. The concentrations of t-PA, PAI and VEGF in samples were determined by ELISA method. The correlations among t-PA, PAI and VEGF expressions were discussed.
RESULTS: The concentrations of t-PA, PAI and VEGF in the PDR group were significantly higher than those in the control group (P<0.001). The t-PA and PAI expressions were highly correlated with the VEGF expression (P<0.001).
CONCLUSION: In addition to VEGF, a variety of bioactive substances, such as t-PA and PAI, are involved in the pathogenesis involved in the angiogenesis of PDR. VEGF can activate t-PA expression, resulting in collagen tissue degradation and angiogenesis. VEGF may also activate the mechanism for endogenous anti-neovascularization.

Entities:  

Keywords:  angiogenesis; plasminogen activator inhibitor; proliferative diabetic retinopathy; tissue plasminogen activator; vascular endothelial growth factor

Year:  2014        PMID: 25349789      PMCID: PMC4206877          DOI: 10.3980/j.issn.2222-3959.2014.04

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  15 in total

1.  Contribution of the blood glucose level in perinatal asphyxia.

Authors:  Pallab Basu; Sabbasachi Som; Nabendu Choudhuri; Harendranath Das
Journal:  Eur J Pediatr       Date:  2008-10-09       Impact factor: 3.183

2.  Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1.

Authors:  Yong Li; Mihwa Choi; Greg Cavey; Jennifer Daugherty; Kelly Suino; Amanda Kovach; Nathan C Bingham; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2005-02-18       Impact factor: 17.970

Review 3.  Role of vascular endothelial growth factor in ocular angiogenesis.

Authors:  Naveed Shams; Tsontcho Ianchulev
Journal:  Ophthalmol Clin North Am       Date:  2006-09

4.  Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence.

Authors:  Hiroyuki Katano; Ken Kamiya; Mitsuhito Mase; Motoki Tanikawa; Kazuo Yamada
Journal:  J Neurosurg       Date:  2006-01       Impact factor: 5.115

5.  Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

Authors:  Andrea Natali; Elena Toschi; Stephanie Baldeweg; Demetrio Ciociaro; Stefania Favilla; Luigi Saccà; Ele Ferrannini
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

6.  Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Hidetaka Noma; Tatsuya Mimura; Shinko Nakamura; Kumi Sakata; Sadao Hori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-17       Impact factor: 3.117

7.  Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.

Authors:  Hiroshi Izuta; Nozomu Matsunaga; Masamitsu Shimazawa; Tetsuya Sugiyama; Tsunehiko Ikeda; Hideaki Hara
Journal:  Mol Vis       Date:  2010-01-29       Impact factor: 2.367

8.  Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Tetsuo Adachi; Masamitsu Shimazawa; Tetsuya Sugiyama; Tsunehiko Ikeda; Hideaki Hara
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

Review 9.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

10.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

View more
  4 in total

1.  Comment on roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy.

Authors:  Abdullah Ilhan; Umit Yolcu; Uzeyir Erdem
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

Review 2.  Resveratrol and Amyloid-Beta: Mechanistic Insights.

Authors:  Yongming Jia; Na Wang; Xuewei Liu
Journal:  Nutrients       Date:  2017-10-14       Impact factor: 5.717

Review 3.  The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy.

Authors:  Meng-Yu Wu; Giou-Teng Yiang; Tzu-Ting Lai; Chia-Jung Li
Journal:  Oxid Med Cell Longev       Date:  2018-09-05       Impact factor: 6.543

4.  Utilizing network pharmacology to explore the underlying mechanism of Radix Salviae in diabetic retinopathy.

Authors:  Chun-Li Piao; Jin-Li Luo; Cheng Tang; Li Wang; Feng-Mei Lian; Xiao-Lin Tong
Journal:  Chin Med       Date:  2019-12-30       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.